In this episode we discuss Optilume, a novel treatment for the urinary symptoms experienced by men due to an enlarged or obstructing prostate (BPH). In previous episodes, we have covered a variety of other BPH treatments ranging from the historical gold standard (TURP) to minimally invasive surgical therapies (MIST) such as Rezum, Urolift, and iTind to more specialized treatments such as HoLEP and robotic simple prostatectomy. So how does Optilume fit into this spectrum of BPH treatments? Does it really stand out from existing treatments or is it just another procedure to add to the list of options in treating BPH? How is the procedure performed? What are the risks and benefits? What is the recovery like? And, of course, how effective is it? To help us answer these questions, we are joined by a true expert.
Dr Dean Elterman is associate professor of urology at the University of Toronto. Dr. Elterman completed his medical degree followed by residency in urologic surgery at the University of Toronto. He became a fellow of the Royal College of Physicians and Surgeons of Canada in 2011. Dr. Elterman completed a two-year fellowship in Voiding Dysfunction, Neuro-Urology, Female Urology and Pelvic Reconstruction at Memorial Sloan-Kettering Cancer Center and New York Presbyterian Hospital/Weill Cornell Medical College in New York City. Dr. Elterman is a member of several professional societies including the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, the Society of Genitourinary Reconstructive Surgeons, the International Neuromodulation Society, and the International Society of Men’s Health.
